132 related articles for article (PubMed ID: 25066861)
1. Understanding and exploiting 5T4 oncofoetal glycoprotein expression.
Stern PL; Brazzatti J; Sawan S; McGinn OJ
Semin Cancer Biol; 2014 Dec; 29():13-20. PubMed ID: 25066861
[TBL] [Abstract][Full Text] [Related]
2. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
Stern PL; Harrop R
Cancer Immunol Immunother; 2017 Apr; 66(4):415-426. PubMed ID: 27757559
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein.
McGinn OJ; Marinov G; Sawan S; Stern PL
J Cell Sci; 2012 Nov; 125(Pt 22):5467-78. PubMed ID: 22956548
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.
Southgate TD; McGinn OJ; Castro FV; Rutkowski AJ; Al-Muftah M; Marinov G; Smethurst GJ; Shaw D; Ward CM; Miller CJ; Stern PL
PLoS One; 2010 Apr; 5(4):e9982. PubMed ID: 20376365
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.
Woods AM; Wang WW; Shaw DM; Ward CM; Carroll MW; Rees BR; Stern PL
Biochem J; 2002 Aug; 366(Pt 1):353-65. PubMed ID: 12003637
[TBL] [Abstract][Full Text] [Related]
6. The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa.
Ali A; Langdon J; Stern P; Partridge M
Oral Oncol; 2001 Jan; 37(1):57-64. PubMed ID: 11120484
[TBL] [Abstract][Full Text] [Related]
7. 5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.
Cappuccini F; Pollock E; Stribbling S; Hill AVS; Redchenko I
Oncotarget; 2017 Jul; 8(29):47474-47489. PubMed ID: 28537896
[TBL] [Abstract][Full Text] [Related]
8. The 5T4 oncofetal glycoprotein does not act as a general organizer of the CXCL12 system in cancer cells.
Puchert M; Koch C; Engele J
Exp Cell Res; 2018 Mar; 364(2):175-183. PubMed ID: 29408206
[TBL] [Abstract][Full Text] [Related]
9. Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy.
Castro FV; Al-Muftah M; Mulryan K; Jiang HR; Drijfhout JW; Ali S; Rutkowski AJ; Kalaitsidou M; Gilham DE; Stern PL
Cancer Immunol Immunother; 2012 Jul; 61(7):1005-18. PubMed ID: 22127365
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.
Al-Taei S; Salimu J; Lester JF; Linnane S; Goonewardena M; Harrop R; Mason MD; Tabi Z
Lung Cancer; 2012 Aug; 77(2):312-8. PubMed ID: 22498111
[TBL] [Abstract][Full Text] [Related]
11. The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency.
Ward CM; Barrow K; Woods AM; Stern PL
J Cell Sci; 2003 Nov; 116(Pt 22):4533-42. PubMed ID: 14576347
[TBL] [Abstract][Full Text] [Related]
12. 5T4 oncotrophoblast glycoprotein: janus molecule in life and a novel potential target against tumors.
Zhao Y; Wang Y
Cell Mol Immunol; 2007 Apr; 4(2):99-104. PubMed ID: 17484803
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen.
Ali S; Mulryan K; Taher T; Stern PL
Cancer Immunol Immunother; 2007 Feb; 56(2):165-80. PubMed ID: 16758205
[TBL] [Abstract][Full Text] [Related]
14. Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.
Griffiths RW; Gilham DE; Dangoor A; Ramani V; Clarke NW; Stern PL; Hawkins RE
Br J Cancer; 2005 Sep; 93(6):670-7. PubMed ID: 16222313
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane.
Carsberg CJ; Myers KA; Evans GS; Allen TD; Stern PL
J Cell Sci; 1995 Aug; 108 ( Pt 8)():2905-16. PubMed ID: 7593330
[TBL] [Abstract][Full Text] [Related]
16. 5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapy.
Amato RJ
Expert Opin Biol Ther; 2010 Feb; 10(2):281-7. PubMed ID: 20088718
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wnt-activated inhibitory factor 1.
Zhao Y; Malinauskas T; Harlos K; Jones EY
Structure; 2014 Apr; 22(4):612-20. PubMed ID: 24582434
[TBL] [Abstract][Full Text] [Related]
18. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells.
Carsberg CJ; Myers KA; Stern PL
Int J Cancer; 1996 Sep; 68(1):84-92. PubMed ID: 8895545
[TBL] [Abstract][Full Text] [Related]
19. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal antigen 5T4 expression as a prognostic factor in patients with gastric cancer.
Naganuma H; Kono K; Mori Y; Takayoshi S; Stern PL; Tasaka K; Matsumoto Y
Anticancer Res; 2002; 22(2B):1033-8. PubMed ID: 12168897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
